CPA
MD icon

Capital Performance Advisors’s Pediatrix Medical MD Stock Holding History

Capital Performance Advisors’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-973
Closed -$11.3K – 1635
2024
Q3 		$11.3K Buy
+973
New +$9.18K ﹤0.01% 798

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Capital Performance Advisors's MD Position: Q4 2024 in Review

Capital Performance Advisors sold out of Pediatrix Medical (MD) in Q4 2024, closing a stake of 973 shares — an estimated $11.3K sold.

Capital Performance Advisors first reported a position in MD in Q3 2024 and held it in 1 quarter. The position peaked at $11.3K in Q3 2024. 229 funds tracked by Wall St. Rank hold MD as of Q4 2024.

  • Capital Performance Advisors reported no remaining Pediatrix Medical position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 973 Pediatrix Medical shares in Q4 2024, an estimated $11.3K.
  • Capital Performance Advisors first reported a position in Pediatrix Medical in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Pediatrix Medical position peaked at $11.3K in Q3 2024.
  • 229 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.